非手術分期法對預測宮頸癌淋巴結轉移的價值_West China Medical Journal

Authors：

 王慧 ,  鄭艾

四川大學華西第二醫院婦科, 成都, 610041;

Corresponding?author：

鄭艾, Email: 894591422@qq.com

Keywords：

宮頸癌; 非手術分期法; 淋巴結轉移

DOI：

10.7507/1002-0179.20140420

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

宮頸癌為女性常見婦科腫瘤之一，具有年輕化趨勢。由于淋巴結轉移與否與患者預后相關，探討無創術前檢查對宮頸癌淋巴結累及情況的有效性，以淋巴結轉移信息來指導治療顯得尤為重要。現對彩色多普勒超聲、CT、正電子發射斷層掃描、磁共振間接淋巴結造影等非手術分期法應用于宮頸癌淋巴結轉移的判定作一綜述，以期為臨床實踐作出一定的指導。

Citation： 王慧, 鄭艾. 非手術分期法對預測宮頸癌淋巴結轉移的價值. West China Medical Journal, 2014, 29(7): 1372-1375. doi: 10.7507/1002-0179.20140420 Copy

1.	Li L, Mori S, Kodama M, et al. Enhanced sonographic imaging to diagnose lymph node metastasis:importance of blood vessel volume and density[J]. Cancer Res, 2013, 73(7):2082-2092.
2.	Sugiyama T, Nishida T, Ushijima K, et al. Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging[J]. J Obstet Gynaecol (Tokyo 1995), 1995, 21(6):551-556.
3.	Sahdev A. Cervical tumors[J]. Semin Ultrasound CT MR, 2010, 31(5):399-413.
4.	Agress H Jr, Wong TZ, Shreve P. Interpretation and reporting of positron emission tomography-computed tomographic scans[J]. Semin Ultrasound CT MR, 2008, 29(4):283-290.
5.	Groheux D, Hindie E, Baillet G, et al. Advantages of PET-CT in the work-up of cervical cancer[J]. Bull Cancer, 2009, 96(2):199-211.
6.	Herrera FG, Prior JO. The role of PET/CT in cervical cancer[J]. Front Oncol, 2013(3):34.
7.	Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer:a prospective study[J]. Gynecol Oncol, 2007, 106(1):29-34.
8.	鄭航, 陳錦章, 羅榮城, 等. ¹⁸F-FDG PET/CT顯像對宮頸癌診斷及治療的影響[J]. 實用癌癥雜志, 2009, 24(5):494-497.
9.	Yildirim Y, Sehirali S, Avci ME, et al. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings[J]. Gynecol Oncol, 2008, 108(1):154-159.
10.	Qiu JT, Ho KC, Lai CH, et al. Supraclavicular lymph node metastases in cervical cancer[J]. Eur J Gynaecol Oncol, 2007, 28(1):33-38.
11.	Kitajima K, Murakami K, Yamasaki E, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer:comparison with PET and enhanced CT[J]. Eur J Nucl Med Mol Imaging, 2009, 36(3):362-372.
12.	Small W, Vern TZ, Rademaker A, et al. A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer[J]. Am J Clin Oncol, 2010, 33(1):89-93.
13.	馬金平. ¹⁸F-氟代脫氧葡萄糖PET/CT在宮頸癌診斷與治療的研究進展[J]. 中華婦幼臨床醫學雜志·電子版, 2011, 7(3):257-260.
14.	Rezvani M, Shaaban A. Imaging of cervical pathology[J]. Clin Obstet Gynecol, 2009, 52(1):94-111.
15.	Feldman AS, McDougal WS, Harisinghani MG. The potential of nanoparticle-enhanced imaging[J]. Urol Oncol, 2008, 26(1):65-73.
16.	Narayanan P, Iyngkaran T, Sohaib SA, et al. Magnetic resonance lymphography:a novel technique for lymph node assessment in gynecologic malignancies[J]. Cancer Biomark, 2009, 5(2):81-88.
17.	Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and Mr lymphangiography[J]. Abdom Imaging, 2003, 28(2):0155-0163.
18.	Luciani A, Itti E, Rahmouni A, et al. Lymph node imaging:basic principles[J]. Eur J Radiol, 2006, 58(3):338-344.
19.	洪穎, 向羅珺, 方婧, 等. 磁共振間接淋巴造影診斷宮頸癌淋巴結轉移的價值[J]. 中國實用婦科與產科雜志, 2011, 27(3):214-216.
20.	郎景和. 淋巴造影術[M]//連利娟. 林巧稚婦科腫瘤學[M]. 2版. 北京:人民衛生出版社, 1994:131.
21.	郎景和, 趙榮國. 卵巢癌的淋巴造影[J]. 中華婦產科雜志, 1989, 24(1):29-31.
22.	Petereit DG, Hartenbach EM, Thomas GM. Para-aortic lymph node evaluation in cervical cancer:the impact of staging upon treatment decisions and outcome[J]. Intern J Gynecol Cancer, 1998, 8(5):353-364.
23.	Jahan N, Narayanan P, Rockall A. Magnetic resonance lymphography in gynaecological malignancies[J]. Cancer Imaging, 2010, 10(1):85-96.
24.	Carnino F, Fuda G, Ciccone G, et al. Significance of lymph node sampling in epithelial carcinoma of the ovary[J]. Gynecol Oncol, 1997, 65(3):467-472.
25.	Gipponi M. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms[J]. Minerva Chir, 2005, 60(4):217-233.
26.	Ikeda S, Yoshimura K, Onda T, et al. Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix[J]. J Obstet Gynaecol Res, 2012, 38(10):1260-1265.
27.	Sato K, Mizuuchi H, Mori Y, et al. Usefulness of CA125 determination in the diagnosis of lymph node metastasis in post menopausal uterine endometrial carcinoma[J]. Nihon Sanka Fujinka Gakkai Zasshi, 1994, 46(4):331-336.
28.	Epenetos AA. Antibody guided lymphangiography in the staging of cervical cancer[J]. Br J Cancer, 1985, 51(6):805-808.

1. Li L, Mori S, Kodama M, et al. Enhanced sonographic imaging to diagnose lymph node metastasis:importance of blood vessel volume and density[J]. Cancer Res, 2013, 73(7):2082-2092.
2. Sugiyama T, Nishida T, Ushijima K, et al. Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging[J]. J Obstet Gynaecol (Tokyo 1995), 1995, 21(6):551-556.
3. Sahdev A. Cervical tumors[J]. Semin Ultrasound CT MR, 2010, 31(5):399-413.
4. Agress H Jr, Wong TZ, Shreve P. Interpretation and reporting of positron emission tomography-computed tomographic scans[J]. Semin Ultrasound CT MR, 2008, 29(4):283-290.
5. Groheux D, Hindie E, Baillet G, et al. Advantages of PET-CT in the work-up of cervical cancer[J]. Bull Cancer, 2009, 96(2):199-211.
6. Herrera FG, Prior JO. The role of PET/CT in cervical cancer[J]. Front Oncol, 2013(3):34.
7. Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer:a prospective study[J]. Gynecol Oncol, 2007, 106(1):29-34.
8. 鄭航, 陳錦章, 羅榮城, 等. ¹⁸F-FDG PET/CT顯像對宮頸癌診斷及治療的影響[J]. 實用癌癥雜志, 2009, 24(5):494-497.
9. Yildirim Y, Sehirali S, Avci ME, et al. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings[J]. Gynecol Oncol, 2008, 108(1):154-159.
10. Qiu JT, Ho KC, Lai CH, et al. Supraclavicular lymph node metastases in cervical cancer[J]. Eur J Gynaecol Oncol, 2007, 28(1):33-38.
11. Kitajima K, Murakami K, Yamasaki E, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer:comparison with PET and enhanced CT[J]. Eur J Nucl Med Mol Imaging, 2009, 36(3):362-372.
12. Small W, Vern TZ, Rademaker A, et al. A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer[J]. Am J Clin Oncol, 2010, 33(1):89-93.
13. 馬金平. ¹⁸F-氟代脫氧葡萄糖PET/CT在宮頸癌診斷與治療的研究進展[J]. 中華婦幼臨床醫學雜志·電子版, 2011, 7(3):257-260.
14. Rezvani M, Shaaban A. Imaging of cervical pathology[J]. Clin Obstet Gynecol, 2009, 52(1):94-111.
15. Feldman AS, McDougal WS, Harisinghani MG. The potential of nanoparticle-enhanced imaging[J]. Urol Oncol, 2008, 26(1):65-73.
16. Narayanan P, Iyngkaran T, Sohaib SA, et al. Magnetic resonance lymphography:a novel technique for lymph node assessment in gynecologic malignancies[J]. Cancer Biomark, 2009, 5(2):81-88.
17. Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and Mr lymphangiography[J]. Abdom Imaging, 2003, 28(2):0155-0163.
18. Luciani A, Itti E, Rahmouni A, et al. Lymph node imaging:basic principles[J]. Eur J Radiol, 2006, 58(3):338-344.
19. 洪穎, 向羅珺, 方婧, 等. 磁共振間接淋巴造影診斷宮頸癌淋巴結轉移的價值[J]. 中國實用婦科與產科雜志, 2011, 27(3):214-216.
20. 郎景和. 淋巴造影術[M]//連利娟. 林巧稚婦科腫瘤學[M]. 2版. 北京:人民衛生出版社, 1994:131.
21. 郎景和, 趙榮國. 卵巢癌的淋巴造影[J]. 中華婦產科雜志, 1989, 24(1):29-31.
22. Petereit DG, Hartenbach EM, Thomas GM. Para-aortic lymph node evaluation in cervical cancer:the impact of staging upon treatment decisions and outcome[J]. Intern J Gynecol Cancer, 1998, 8(5):353-364.
23. Jahan N, Narayanan P, Rockall A. Magnetic resonance lymphography in gynaecological malignancies[J]. Cancer Imaging, 2010, 10(1):85-96.
24. Carnino F, Fuda G, Ciccone G, et al. Significance of lymph node sampling in epithelial carcinoma of the ovary[J]. Gynecol Oncol, 1997, 65(3):467-472.
25. Gipponi M. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms[J]. Minerva Chir, 2005, 60(4):217-233.
26. Ikeda S, Yoshimura K, Onda T, et al. Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix[J]. J Obstet Gynaecol Res, 2012, 38(10):1260-1265.
27. Sato K, Mizuuchi H, Mori Y, et al. Usefulness of CA125 determination in the diagnosis of lymph node metastasis in post menopausal uterine endometrial carcinoma[J]. Nihon Sanka Fujinka Gakkai Zasshi, 1994, 46(4):331-336.
28. Epenetos AA. Antibody guided lymphangiography in the staging of cervical cancer[J]. Br J Cancer, 1985, 51(6):805-808.

Previous Article
無創脈搏血紅蛋白監測技術的研究進展
Next Article
小兒ChiariⅠ型畸形合并脊髓空洞癥研究進展

West China Medical Journal

非手術分期法對預測宮頸癌淋巴結轉移的價值

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content